Haemophilia care in Asia: Learning from clinical practice in some Asian countries
Pantep Angchaisuksiri(Mahidol University), Raymond Wong(Chinese University of Hong Kong), Roy Gomez(Pfizer (Belgium)), Pei‐Chin Lin(Kaohsiung Medical University), Novie Amelia Chozie(University of Indonesia), Zulaiha Muda(Hospital Kuala Lumpur), Pol Chewcharat(Pfizer (United States)), Darintr Sosothikul(Thai Red Cross Society), Marilou Amurao‐Abiera(Philippine Medical Association), Nguyen Thi(National Hemophilia Foundation), Tien Sim Leng(Singapore General Hospital), Sheng‐Chien Chou(National Taiwan University Hospital), Tulika Seth(Manipal Academy of Higher Education)
Cited by 13
Related Papers
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
|Blood Advances|2020|218
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198